Niquitin Mini Citrus (Nicotine)

Nicotine, the active ingredient in Niquitin Mini Citrus, is a nicotine replacement therapy presented as an oral formulation for oral use. It helps adults who are trying to quit smoking by reducing withdrawal symptoms and cravings associated with nicotine dependence.

GNH USA supplies Niquitin Mini Citrus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Niquitin Mini Citrus, a nicotine replacement therapy, is used to support smoking cessation and manage nicotine dependence.

- Smoking cessation: helps adult smokers quit by reducing cravings and withdrawal symptoms. - Nicotine dependence: assists individuals with physiological dependence on nicotine to transition away from tobacco. - Relapse prevention: supports former smokers in maintaining abstinence and preventing return to smoking.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Headache - Dizziness - Insomnia or sleep disturbances - Heartburn or acid reflux

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Rapid or irregular heartbeat - Severe dizziness or fainting - Vomiting blood or severe gastrointestinal bleeding - Seizures

Before using Niquitin Mini Citrus, consider the following precautions: - Assess nicotine use history: determine baseline dependence before starting. - Avoid use in children and adolescents: not approved for individuals under 18 years of age. - Monitor cardiovascular status: use with caution in patients with heart disease or hypertension. - Do not combine with other nicotine products: risk of nicotine overdose. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Niquitin Mini Citrus may interact with other medicines. Review the following categories:

Major Interactions (Avoid): - CYP1A2 substrates (e.g., theophylline, clozapine): nicotine can induce metabolism, reducing efficacy. - Insulin or oral hypoglycemics: nicotine may affect blood glucose control. - Warfarin: nicotine may alter anticoagulant effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may blunt heart‑rate response. - Selective serotonin reuptake inhibitors (SSRIs): monitor for increased side effects such as anxiety or insomnia.